PMID- 29039495 OWN - NLM STAT- MEDLINE DCOM- 20180720 LR - 20180720 IS - 1791-244X (Electronic) IS - 1107-3756 (Linking) VI - 40 IP - 6 DP - 2017 Dec TI - Protective effects of neem (Azadirachta indica A. Juss.) leaf extract against cigarette smoke- and lipopolysaccharide-induced pulmonary inflammation. PG - 1932-1940 LID - 10.3892/ijmm.2017.3178 [doi] AB - Neem (Azadirachta indica A. Juss.) leaf has been reported to exert anti-inflammatory, antibacterial and antioxidant effects. The purpose of this study was to investigate the protective effects of neem leaf extract (NLE) against cigarette smoke (CS)- and lipopolysaccharide (LPS)-induced pulmonary inflammation. Treatment with NLE significantly attenuated the infiltration of inflammatory cells, such as neutrophils and macrophages in bronchoalveolar lavage fluid (BALF). NLE also reduced the production of reactive oxygen species and the activity of neutrophil elastase in BALF. Moreover, NLE attenuated the release of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 in BALF. NLE inhibited the recruitment of inflammatory cells and the expression of monocyte chemoattractant protein-1 (MCP-1) in the lungs of mice with CS- and LPS-induced pulmonary inflammation. NLE also decreased the expression of inducible nitric oxide synthase (iNOS) in the lungs of the mice CS- and LPS-induced pulmonary inflammation. Furthermore, treatment with NLE significantly attenuated the activation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in the lungs mice exposed to CS and LPS. NLE also inhibited the phosphorylation of nuclear factor (NF)-kappaB and inhibitor of NF-kappaB (IkappaB) in the lungs of mice expose to CS and LPS. These findings thus suggest that NLE has potential for use in the treatment of chronic obstructive pulmonary disease. FAU - Lee, Jae-Won AU - Lee JW AD - Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungju‑si, Chungbuk 363‑883, Republic of Korea. FAU - Ryu, Hyung Won AU - Ryu HW AD - Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungju‑si, Chungbuk 363‑883, Republic of Korea. FAU - Park, So-Yeon AU - Park SY AD - Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungju‑si, Chungbuk 363‑883, Republic of Korea. FAU - Park, Hyun Ah AU - Park HA AD - Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungju‑si, Chungbuk 363‑883, Republic of Korea. FAU - Kwon, Ok-Kyoung AU - Kwon OK AD - Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungju‑si, Chungbuk 363‑883, Republic of Korea. FAU - Yuk, Heung Joo AU - Yuk HJ AD - Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungju‑si, Chungbuk 363‑883, Republic of Korea. FAU - Shrestha, Krishna K AU - Shrestha KK AD - Ethnobotanical Society of Nepal (ESON), Central Department of Botany, Tribhuvan University, Kathmandu 44618, Nepal. FAU - Park, Minwoo AU - Park M AD - SciTech Korea, Gangbuk-gu, Seoul 142-705, Republic of Korea. FAU - Kim, Jung Hee AU - Kim JH AD - Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungju‑si, Chungbuk 363‑883, Republic of Korea. FAU - Lee, Sangwoo AU - Lee S AD - International Biological Material Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea. FAU - Oh, Sei-Ryang AU - Oh SR AD - Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungju‑si, Chungbuk 363‑883, Republic of Korea. FAU - Ahn, Kyung-Seop AU - Ahn KS AD - Natural Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Chungju‑si, Chungbuk 363‑883, Republic of Korea. LA - eng PT - Journal Article DEP - 20171010 PL - Greece TA - Int J Mol Med JT - International journal of molecular medicine JID - 9810955 RN - 0 (Interleukin-6) RN - 0 (Lipopolysaccharides) RN - 0 (Plant Extracts) RN - 0 (Reactive Oxygen Species) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Animals MH - Azadirachta/*chemistry MH - Bronchoalveolar Lavage Fluid/chemistry MH - Gene Expression Regulation/drug effects MH - Humans MH - Interleukin-6/genetics MH - Lipopolysaccharides/toxicity MH - Lung/drug effects/pathology MH - Mice MH - Plant Extracts/*administration & dosage/chemistry MH - Plant Leaves/chemistry MH - Pneumonia/chemically induced/*drug therapy/genetics/pathology MH - Pulmonary Disease, Chronic Obstructive/*drug therapy/genetics/pathology MH - Reactive Oxygen Species/metabolism MH - Smoking/adverse effects MH - Tumor Necrosis Factor-alpha/genetics EDAT- 2017/10/19 06:00 MHDA- 2018/07/22 06:00 CRDT- 2017/10/18 06:00 PHST- 2016/03/30 00:00 [received] PHST- 2017/09/25 00:00 [accepted] PHST- 2017/10/19 06:00 [pubmed] PHST- 2018/07/22 06:00 [medline] PHST- 2017/10/18 06:00 [entrez] AID - 10.3892/ijmm.2017.3178 [doi] PST - ppublish SO - Int J Mol Med. 2017 Dec;40(6):1932-1940. doi: 10.3892/ijmm.2017.3178. Epub 2017 Oct 10.